(1R,2S)-[2-(4-Bromo-phenyl)-cyclopropyl]-carbamic acid tert-butyl ester CAS:907196-12-7

( (1R,2S)-[2-(4-Bromo-phenyl)-cyclopropyl]-carbamic acid tert-butyl ester can be utilized in medicinal chemistry as an intermediate for developing drug candidates targeting specific biological pathways or disease mechanisms. Researchers can assess its pharmacological properties by examining its interactions with biological targets to determine its potential therapeutic applications. The compound's chiral nature enables the design of enantiomerically pure compounds with improved bioactivity and reduced off-target effects. In organic synthesis, this compound serves as a versatile starting material for accessing structurally diverse molecules through derivatization or transformations. Its incorporation into synthetic pathways allows for the construction of complex molecular architectures for investigating structure-activity relationships or creating compounds with tailored properties. By leveraging its stereochemistry and reactivity, researchers can advance synthetic methodologies and contribute to the development of innovative compounds for various scientific and industrial purposes. Overall, ( (1R,2S)-[2-(4-Bromo-phenyl)-cyclopropyl]-carbamic acid tert-butyl ester demonstrates versatility and potential in drug discovery, organic synthesis, and chemical innovation, highlighting its significance in advancing scientific knowledge and pharmaceutical advancements.